CNS Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2018 | $-716.4K | $-716.4K | $0 | $110.2K |
| FY2019 | $-3.6M | $-3.6M | $20.1K | $477.1K |
| FY2020 | $-7.3M | $-7.3M | $17.9K | $1.3M |
| FY2021 | $-13.5M | $-13.5M | $5.7K | $1.7M |
| FY2022 | $-10.6M | $-10.6M | $4.4K | $1.2M |
| FY2023 | $-14.1M | $-14.1M | $3.9K | $1.0M |
| FY2024 | $-17.1M | $-17.1M | $4.2K | $839.0K |
| FY2025 | $-13.8M | $-13.8M | $18.2K | $187.7K |